Seoul, South Korea

Gene Lee

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Nano Intelligent Biomedical Engineering Corporation Co. Ltd., Seoul National University, Snu Rdb Foundation. Active years: 2011-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gene Lee. Retrieved from https://idiyas.com/inventor/gene-lee-zeh44els

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Gene Lee**

Introduction

Gene Lee, an accomplished inventor based in Seoul, South Korea, holds a remarkable portfolio of two patents that embody his innovative spirit. His work primarily focuses on advancements in biotechnology and regenerative medicine, showcasing his commitment to improving human health through scientific innovation.

Latest Patents

Gene Lee's latest patents include groundbreaking developments in the field of cellular reprogramming and bone regeneration. The first patent, titled "Cell permeable fusion protein for facilitating reprogramming induction and use thereof," introduces a novel method for preparing reprogramming induced pluripotent stem cells from human-derived somatic cells. This method utilizes a fusion protein that combines a reprogramming inducing factor with a cell-permeable peptide (CPP), thereby enhancing the efficiency and stability of the induced pluripotent stem cell production. This invention surpasses existing viral peptide transporters, significantly increasing the efficacy of cell reprogramming.

The second patent, "Composition of bone formation with PHSRN-RGD containing oligopeptide," discloses an innovative oligopeptide that promotes bone formation. This composition, featuring the PHSRN-RGD oligopeptide, enhances osteoblastic cell adhesion and differentiation, ultimately boosting the regenerative abilities of bone and periodontal tissues. These advancements position his inventions as pivotal tools in regenerative treatments.

Career Highlights

Throughout his career, Gene Lee has contributed to the field while working with notable organizations such as the Seoul National University Industry Foundation and the Snur & Db Foundation. His work in these institutions has enabled him to push the boundaries of biomedical research and innovation.

Collaborations

Gene Lee has collaborated with esteemed colleagues, including Chong-Pyoung Chung and Young Bae Ku. These partnerships have fostered a conducive environment for innovation and research, facilitating the development of impactful inventions that can advance medical science.

Conclusion

Gene Lee's inventive contributions reflect his dedication to harnessing the power of science for better health outcomes. Through his patented inventions, he has opened new pathways in cell reprogramming and bone regeneration, underscoring the important role of inventors in advancing medical technology. His achievements epitomize the spirit of innovation and the potential of collaborative research in driving the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…